News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Torrent Pharmaceuticals Ltd. Gains on FDA Nod for Generics of Actos


2/15/2013 8:18:29 AM

Torrent Pharmaceuticals gained more than one percent intraday on Friday as the company received approval from US FDA for generics of Actos and Actoplus Met. Takeda Global's Actos and Actoplus are anti-diabetes drugs. At 15:08 hours IST, shares rose 0.71 percent to Rs 700 on Bombay Stock Exchange.

Read at Money Control


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES